BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 35789548)

  • 1. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.
    Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H
    Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a Novel Mitochondria-Associated Gene Model for Assessing ESCC Immune Microenvironment and Predicting Survival.
    Wang X; Zhang Z; Shi Y; Zhang W; Su C; Wang D
    J Microbiol Biotechnol; 2024 May; 34(5):1164-1177. PubMed ID: 38719775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma.
    Zhang M; Liang Y; Song P
    J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
    Li C; Song W; Zhang J; Luo Y
    Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
    Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
    Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.
    Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X
    BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VBP1 promotes tumor proliferation as a part of the hypoxia-related signature in esophageal squamous cell carcinoma.
    Miao H; Gao W; Zhong L; Li H; Chen D; Xu C; Wen Z; Chen Y
    Hum Cell; 2024 May; ():. PubMed ID: 38700744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Risk Models Using Epithelial Cells Identify β-Sitosterol as a Potential Therapeutic Target Against Esophageal Squamous Cell Carcinoma.
    Zhang Z; Shang B; Mao X; Shi Y; Zhang G; Wang D
    Int J Gen Med; 2024; 17():1193-1211. PubMed ID: 38559590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating bulk and single-cell sequencing data to construct a Scissor
    Cheng M; Xiong J; Liu Q; Zhang C; Li K; Wang X; Chen S
    Cancer Immunol Immunother; 2024 Apr; 73(6):97. PubMed ID: 38619620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of prognostic and immunotherapeutic responses in esophageal squamous carcinoma based on hypoxia phenotype-related genes.
    Xie K; Chen Z; Feng J; Pan L; Wang N; Luo J; Yao Y; Ma H; Feng Y; Jiang W
    Front Pharmacol; 2024; 15():1344317. PubMed ID: 38515846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Prognostic Model for Gastric Cancer Based on Apoptosis- and Hypoxia-Related Genes: Predictive Insights into Survival and Immune Landscape.
    Zhu J; Ma Y
    J Environ Pathol Toxicol Oncol; 2024; 43(3):81-93. PubMed ID: 38608147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for predicting prognosis in patients with esophageal squamous cell carcinoma based on joint representation learning.
    Yu J; Wu X; Lv M; Zhang Y; Zhang X; Li J; Zhu M; Huang J; Zhang Q
    Oncol Lett; 2020 Dec; 20(6):387. PubMed ID: 33193847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell transcriptome sequencing analysis reveals intra-tumor heterogeneity in esophageal squamous cell carcinoma.
    Nie Y; Yao G; Wei Y; Wu S; Zhang W; Xu X; Li Q; Zhou F; Yang Z
    Environ Toxicol; 2024 Apr; ():. PubMed ID: 38572681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer.
    Xu Y; Shen Y; Bhandari A; Hirachan S; Wang O; Xia E
    Curr Med Chem; 2024; 31(15):2073-2089. PubMed ID: 37282654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes.
    Shi W; Dong J; Zhong B; Hu X; Zhao C
    Mol Biotechnol; 2024 May; ():. PubMed ID: 38806990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognosis of ADAMTS18 in different tumors.
    Guo W; Zhang Y
    Front Oncol; 2024; 14():1347633. PubMed ID: 38482210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of IL-18 in P2RX7-Mediated Antitumor Immunity.
    Janho Dit Hreich S; Hofman P; Vouret-Craviari V
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis.
    Gao Y; Guan L; Jia R; Xiao W; Han Y; Li Y; Tang P; Yu Z; Zhang H
    BMC Cancer; 2023 May; 23(1):417. PubMed ID: 37158817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma.
    Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S
    BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.